Infection Medicine (BMC)
141 – 150 of 1817
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Understanding Post-Sepsis Syndrome : How Can Clinicians Help?
(
- Contribution to journal › Scientific review
-
Mark
The First Swedish Outbreak with VIM-2-Producing Pseudomonas aeruginosa, Occurring between 2006 and 2007, Was Probably Due to Contaminated Hospital Sinks
(
- Contribution to journal › Article
-
Mark
A calcium sulphate/hydroxyapatite ceramic biomaterial carrier for local delivery of tobramycin in bone infections : Analysis of rheology, drug release and antimicrobial efficacy
(
- Contribution to journal › Article
-
Mark
Influenza A subtype H3N2 is associated with an increased risk of hospital dissemination – an observational study over six influenza seasons
(
- Contribution to journal › Article
-
Mark
Pathogen-driven degradation of endogenous and therapeutic antibodies during streptococcal infections
(
- Contribution to journal › Article
-
Mark
Analysis of Neutrophil and Monocyte Inflammation Markers in Response to Gram-Positive Anaerobic Cocci
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Recombinant α
1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a
177Lu-DOTATATE Mouse Radiation Model.
(
- Contribution to journal › Article
-
Mark
Factors associated to a low level of physical activity after out-of- hospital cardiac arrest: Results from the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial
(
- Contribution to journal › Published meeting abstract
-
Mark
The intracellular helical bundle of human glucose transporter GLUT4 is important for complex formation with ASPL
(
- Contribution to journal › Article
-
Mark
Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
(
- Contribution to journal › Article